D. E. Shaw & Co., Inc. Icon PLC Transaction History

D. E. Shaw & Co., Inc.

$100 Billion
Q1 2025

A detailed history of D. E. Shaw & Co., Inc. transactions in Icon PLC stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 1,661,736 shares of ICLR stock, worth $249 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

1,661,736

Previous 1,116,205 48.87%

Holding current value

$249 Million

Previous $234 Million 24.23%

% of portfolio

0.29%

Previous 0.19%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$174.99 - $222.58 $95.5 Million - $121 Million	545,531 Added 48.87%	1,661,736 $291 Million
Q4 2024 Feb 14, 2025	BUY	$187.22 - $297.57 $178 Million - $283 Million	950,740 Added 574.59%	1,116,205 $234 Million
Q3 2024 Nov 14, 2024	BUY	$280.48 - $346.2 $24 Million - $29.7 Million	85,726 Added 107.51%	165,465 $47.6 Million
Q2 2024 Aug 14, 2024	SELL	$288.23 - $331.73 $30.7 Million - $35.3 Million	-106,468 Reduced 57.18%	79,739 $25 Million
Q1 2024 May 15, 2024	BUY	$247.84 - $340.0 $23.7 Million - $32.5 Million	95,464 Added 105.2%	186,207 $62.6 Million
Q4 2023 Feb 14, 2024	BUY	$222.83 - $285.76 $20.2 Million - $25.9 Million	90,743 New	90,743 $25.7 Million
Q1 2023 May 15, 2023	SELL	$193.59 - $245.33 $2.95 Million - $3.74 Million	-15,233 Reduced 17.15%	73,575 $15.7 Million
Q4 2022 Feb 14, 2023	BUY	$173.9 - $224.8 $14.3 Million - $18.5 Million	82,185 Added 1240.9%	88,808 $17.3 Million
Q3 2022 Nov 14, 2022	SELL	$183.25 - $247.5 $867,688 - $1.17 Million	-4,735 Reduced 41.69%	6,623 $1.22 Million
Q2 2022 Aug 15, 2022	SELL	$197.3 - $261.32 $665,492 - $881,432	-3,373 Reduced 22.9%	11,358 $2.46 Million
Q1 2022 May 16, 2022	SELL	$216.09 - $296.03 $1.79 Million - $2.45 Million	-8,270 Reduced 35.95%	14,731 $3.58 Million
Q4 2021 Feb 14, 2022	SELL	$258.11 - $309.7 $5 Million - $6 Million	-19,376 Reduced 45.72%	23,001 $7.12 Million
Q3 2021 Nov 15, 2021	SELL	$208.53 - $283.04 $56.7 Million - $76.9 Million	-271,664 Reduced 86.51%	42,377 $11.1 Million
Q2 2021 Aug 16, 2021	SELL	$194.07 - $232.2 $318,857 - $381,504	-1,643 Reduced 0.52%	314,041 $64.9 Million
Q1 2021 May 17, 2021	BUY	$171.87 - $220.96 $36.7 Million - $47.2 Million	213,632 Added 209.34%	315,684 $62 Million
Q4 2020 Feb 16, 2021	SELL	$180.3 - $214.08 $6.4 Million - $7.6 Million	-35,506 Reduced 25.81%	102,052 $19.9 Million
Q3 2020 Nov 16, 2020	SELL	$166.91 - $196.1 $3.31 Million - $3.88 Million	-19,809 Reduced 12.59%	137,558 $26.3 Million
Q2 2020 Aug 14, 2020	BUY	$129.79 - $170.94 $3.26 Million - $4.3 Million	25,146 Added 19.02%	157,367 $26.5 Million
Q1 2020 May 15, 2020	SELL	$115.95 - $177.22 $11.8 Million - $18 Million	-101,543 Reduced 43.44%	132,221 $18 Million
Q4 2019 Feb 14, 2020	SELL	$139.48 - $172.23 $15.9 Million - $19.6 Million	-113,956 Reduced 32.77%	233,764 $40.3 Million
Q3 2019 Nov 14, 2019	SELL	$146.89 - $161.41 $3.6 Million - $3.95 Million	-24,499 Reduced 6.58%	347,720 $51.2 Million
Q2 2019 Aug 14, 2019	BUY	$129.99 - $153.97 $3.34 Million - $3.96 Million	25,723 Added 7.42%	372,219 $57.3 Million
Q1 2019 May 15, 2019	BUY	$121.3 - $146.95 $39.6 Million - $48 Million	326,542 Added 1636.47%	346,496 $47.3 Million
Q4 2018 Feb 14, 2019	BUY	$119.37 - $153.29 $1.67 Million - $2.14 Million	13,953 Added 232.51%	19,954 $2.58 Million
Q3 2018 Nov 14, 2018	SELL	$131.3 - $153.75 $7.13 Million - $8.35 Million	-54,317 Reduced 90.05%	6,001 $923,000
Q4 2017 Feb 14, 2018	BUY	$111.14 - $123.05 $4.41 Million - $4.88 Million	39,688 Added 192.38%	60,318 $6.77 Million
Q3 2017 Nov 14, 2017	BUY	$101.4 - $116.62 $2.09 Million - $2.41 Million	20,630	20,630 $2.35 Million

Others Institutions Holding ICLR

# of Institutions

617

Shares Held

74.3M

Call Options Held

83.2K

Put Options Held

128K

View Full List

About ICON PLC

Ticker ICLR
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 81,526,600
Market Cap $12.2B
Description
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development proces...

More about ICLR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account